Roche media release

For the past 20 years, we have been dedicated to transforming the lives of people with breast cancer through our science-driven approach. Today, we are pleased to announce another important milestone, that the CHMP has recommended EU approval of our cancer immunotherapy for certain people with triple-negative breast cancer.

Go to the full article >>